PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50123C00056Advance the development of POTENT cross-reactive — Modex Therapeutics LLC

Modex Therapeutics LLC holds $103.5M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Feb 29, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Department of Health and Human Services (HHS)
Agency
Modex Therapeutics LLC
Recipient
Feb 29, 2028
PoP end
$103.5M
Obligated
541714
NAICS
AN13
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE
Contract number75A50123C00056
AgencyDepartment of Health and Human Services (HHS)
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentModex Therapeutics LLC
UEICDVMNSMRDTW8
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
Place of performanceNATICK, MA
Related solicitationBAA-18-100-SOL-0003
PoP end (current)Feb 29, 2028
PoP end (w/ options)Jan 18, 2030
Obligated$103.5M

ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND… is a federal NONE award for Department of Health and Human Services (HHS) held by Modex Therapeutics LLC. Estimated value $110M ($103.5M obligated). Current period of performance ends Feb 29, 2028 (potential Jan 18, 2030). Last award drew 1 bidder. Place of performance: NATICK, MA. Related solicitation BAA-18-100-SOL-0003.

ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.

Recompete timing

Public
● Expiring in 520 days

Current PoP ends Feb 29, 2028 (520 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Aug 29, 2026.

Bonuses end Sept 30

Want the durability read on 75A50123C00056? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Modex Therapeutics LLC — $103.5M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$103.5M · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50123C00056?

75A50123C00056 (Advance the development of POTENT cross-reactive) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $110M, currently held by Modex Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50123C00056?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00056 to Modex Therapeutics LLC.

Who is the incumbent on 75A50123C00056?

Modex Therapeutics LLC is the incumbent with $103.5M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Feb 29, 2028.

When does Modex Therapeutics LLC’s 75A50123C00056 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 29, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50123C00056? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50123C00056